The leadership of the BU CTSI is driven by a team deeply integrated within Boston University, Boston Medical Center Health System and the Veterans Administration Boston Healthcare System, showing a strong commitment to cross-campus and cross-institutional collaboration.

BU CTSI Leadership

David Center, MD has served the BU CTSI Lead PI and Associate Provost for Translational Research since 2008. As the founding PI, Dr. Center has shaped the hub and positioned our leadership in areas like community engagement, clinical and bioinformatics, and regenerative medicine. Dr. Center is a member of the Medical Campus Provost’s Council and meets with Provost Antman and senior leaders weekly, exemplifying one way in which the BU CTSI is integrated into the institutional structure.

Megan Bair-Merritt, MD, MSCE has been multi-PI since 2019. She serves as BMCHS’s inaugural Chief Scientific Officer, and is Professor of Pediatrics. Dr. Bair-Merritt meets weekly with hospital leadership, exemplifying how the BU CTSI is integrated into BMCHS’s leadership structure, and facilitating coordination and sustainability.

Terence M. Keane, PhD is a Senior Advisor to the BU CTSI and the Associate Chief of Staff for Research of the VABHS and an authority on PTSD. Dr. Keane has been a long-standing relationship with the BU CTSI in support of translational science. Over the course of his career, Dr. Keane has held many leadership roles in national and international professional societies.

Helia Morris, MSM has been the Executive Director of the BU CTSI since 2014. Before that, she had over 25 years of management and grant related experience at Harvard University, including nine years in Harvard’s Office of Sponsored Programs. She leads BU CTSI’s operations and administration, personnel, budgets, and quality assurance. She serves as the liaison to NCATS Administrators Network and the Hub Lisian for the Trial Innovation Network (TIN).

Rebecca Lobb, ScD, MPH serves as the Director of Integration & Strategic Partnerships (I&SP). She oversees integration across all companion grants (KL2 and a pre-doctoral TL1), partners and collaborators, and the CTSA Consortium. She nurtures productive collaboration ensuring partner/collaborator organizations’ purpose and goals will enhance, and are aligned with, the BU CTSI hub; and, monitoring relationships, performance, and competing priorities for better alignment.

Kim Brimhall, PhD directs Evaluation. Dr. Brimhall is a Clinical Associate Professor in the Department of Health Law, Management and Policy at the BU School of Public Health. She has extensive mixed methods expertise and uses participatory approaches to ensure the timely use of evaluative data to guide decision-making used for continuous improvement.